Pay in 4 interest-free payments of $7.36 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
FDA Submission Timeline Based on the TRIUMPH-4 success and expected 2026 readouts, analysts predict: Late 2026: Completion of core TRIUMPH trials Q4 2026 or Q1 2027: New Drug Application (NDA) submission to FDA Mid to Late 2027: Potential FDA approval Early 2028: Commercial launch Eli Lilly has not officially confirmed these timelines, but the company has indicated it will submit for regulatory approval once sufficient Phase 3 data is available
These concentrations were specifically chosen to allow the pen mechanism to deliver therapeutic doses in manageable volumes
Henry Meds can be cheaper at higher maintenance doses on a multi-month plan
The Journal of Clinical Investigation, 79 (2), 616619
US$ 27.90
US$ 29.95
US$ 20.39
